Adaptive Biotech Insider Sells $554K as Revenue Jumps 55%, but Here's What Investors Should Focus On

The President and COO of Adaptive Biotechnologies sold 38,120 shares for approximately $554,000 at a weighted average price of $14.53 per share across April 1–2, 2026. This is a routine insider sale with no accompanying corporate guidance or material company announcement and is unlikely to have a meaningful impact on the stock.

Analysis

The President and COO of Adaptive Biotechnologies sold 38,120 shares for approximately $554,000 at a weighted average price of $14.53 per share across April 1–2, 2026. This is a routine insider sale with no accompanying corporate guidance or material company announcement and is unlikely to have a meaningful impact on the stock.